Assessing Influenza and SARS‐CoV‐2 Coinfection in Brazil: A Comprehensive Study of Patient Outcomes From 2020 to 2023
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70639 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von L T A Gaklik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Virology Laboratory, School of Health Sciences, Federal University of Rondonópolis, Rondonópolis, Mato Grosso, Brazil. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Coinfection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Influenza and SARS‐CoV‐2 are major respiratory pathogens that have impacted global health, sharing similar transmission routes and clinical symptoms. The COVID‐19 pandemic brought attention to coinfection with these viruses, which has been associated with worse clinical outcomes, but the full extent of this impact remains underexplored. As both viruses circulate together during seasonal outbreaks, understanding their coinfection dynamics is crucial for public health response. This retrospective observational study analyzed data from over 30 000 hospitalized patients sourced from the Brazilian Epidemiological Surveillance System (SIVEP‐Gripe). Patients were classified into two groups: influenza mono‐infection and influenza‐SARS‐CoV‐2 coinfection. Descriptive statistics and multivariate logistic regression were performed to evaluate associations with primary (mortality) and secondary (ICU admission) outcomes. Among approximately 3.7 million reported severe acute respiratory syndrome cases, 35 831 were influenza‐infected, with 1763 (4.9%) coinfected with SARS‐CoV‐2. Coinfected patients exhibited nearly double the risk of death (aOR: 1.87, 95% CI: 1.52−2.30) and a significantly higher likelihood of ICU admission (aOR: 1.27, 95% CI: 1.07–1.52), compared to those with influenza alone. Coinfected patients also presented with more severe respiratory symptoms and longer hospital stays. Coinfection with influenza and SARS‐CoV‐2 is associated with significantly worse clinical outcomes, including higher mortality and increased need for intensive care. Early identification and tailored management strategies for coinfected patients are essential to improving patient outcomes, particularly for those with underlying comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology and Virology Laboratory, School of Health Sciences, Federal University of Rondonópolis, Rondonópolis, Mato Grosso, Brazil.
ORCID-Profile: B M Carneiro
Zitieren
APA
Gaklik, L. T. A., & Carneiro, B. M. (2025). Assessing Influenza and SARS‐CoV‐2 Coinfection in Brazil: A Comprehensive Study of Patient Outcomes From 2020 to 2023. Journal of Medical Virology. https://doi.org/10.1002/jmv.70639
Vancouver
Gaklik LTA, Carneiro BM. Assessing Influenza and SARS‐CoV‐2 Coinfection in Brazil: A Comprehensive Study of Patient Outcomes From 2020 to 2023. Journal of Medical Virology. 2025. doi:10.1002/jmv.70639
BibTeX
@article{Gaklik2025,
author = {Gaklik, L T A and Carneiro, B M},
title = {Assessing Influenza and SARS‐CoV‐2 Coinfection in Brazil: A Comprehensive Study of Patient Outcomes From 2020 to 2023},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70639}
}
EUVIMED